EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study

Rita S Patarrão, Maria João Meneses, Hilda E Ghadieh, Laura Herrera iD, Sérgio Duarte, Rogério T Ribeiro, João F Raposo, Verena Schmitt, Bernhard B Singer, Amalia Gastaldelli iD, Carlos Penha-Gonçalves, Sonia M Najjar und 1 weitere

European Journal of Clinical Investigation · 2024-12 · 54 (S2)

DOI: 10.1111/eci.14344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 14.12.2024. Verfasst von Rita S Patarrão und 12 weiteren Autor:innen. Beteiligte Einrichtung: iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Antigens, CD, Insulin Resistance, Insulin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sociedade Portuguesa De Diabetologia, NIMHD NIH HHS, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes (T2DM) and obesity are characterized by altered insulin metabolism and action. Reduced hepatic insulin clearance is increasingly recognized as a key contributor to hyperinsulinemia and insulin resistance. CEACAM1 promotes hepatic insulin clearance, and its loss in hepatocytes is associated with reduced insulin clearance in mice and men. This study examines whether CEACAM1 circulating levels reflect compromised insulin metabolism and resistance in the PREVADIAB2 cohort.

Methods

A total of 1019 individuals from the PREVADIAB2 cohort were evaluated for diabetes by 75 g‐OGTT and classified according to WHO 2019 criteria. CEACAM1 circulating levels were measured by ELISA, and insulin metabolism parameters were calculated. Hierarchical clustering of insulin metabolic indices and CEACAM1 levels was performed. Statistical significance was assessed using Kruskal–Wallis and Wilcoxon–Mann–Whitney tests.

Results

BMI, insulin resistance (HOMA‐IR), and hepatic steatosis progressively increased with disease severity. Insulin secretion rose and its clearance declined in parallel to circulating CEACAM1 levels in prediabetes and T2DM, indicating compensatory hyperinsulinemia. Hierarchical metabolic clustering identified four clusters with distinct patterns and further showed that insulin clearance positively correlated with circulating CEACAM1, especially in individuals with normoglycemia, lower obesity and hepatic steatosis. This suggests that circulating CEACAM1 can reflect the status of hepatic insulin clearance.

Conclusions

This study demonstrates a progressive increase in insulin resistance and hyperinsulinemia in parallel to elevated BMI and hepatic steatosis prevalence, accompanied by declining circulating CEACAM1 levels. Cluster analysis further linked reduced insulin clearance to lower circulating CEACAM1 levels, suggesting its potential usefulness as a biomarker for metabolic disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Antigens, CDInsulin ResistanceInsulinCell Adhesion MoleculesDisease ProgressionHumansMaleMiddle AgedFemaleObesityHyperinsulinismPortugalAdultPrediabetic StateBody Mass IndexFatty LiverAgedInsulin Secretion

Stichwörter der Autor:innen

CEACAM1diabeteshepatic steatosishyperinsulinemiainsulin clearanceinsulin resistance

Substanzen

CD66 antigensAntigens, CDInsulinCell Adhesion Molecules

Autor:innen und Institutionen

  • iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal.
  • Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Balamand, Al-Koura, Lebanon.
  • APDP - Diabetes Portugal, Education and Research Center, Lisbon, Portugal.
  • Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Portuguese Society of Diabetology, Lisbon, Portugal.

ORCID-Profile: Laura Herrera, Amalia Gastaldelli, M Paula Macedo

Förderung

  • Sociedade Portuguesa De Diabetologia
  • NIMHD NIH HHS
  • Fundação para a Ciência e a Tecnologia
  • US National Institutes of Health
  • NIDDK NIH HHS
  • European Commission, Horizon Europe Framework Programme, PAS GRAS
  • European Commission
  • National Institutes of Health

Zitieren

APA

Patarrão, R. S., Meneses, M. J., Ghadieh, H. E., Herrera, L., Duarte, S., Ribeiro, R. T., Raposo, J. F., Schmitt, V., Singer, B. B., Gastaldelli, A., Penha-Gonçalves, C., Najjar, S. M., & Macedo, M. P. (2024). Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study. European Journal of Clinical Investigation, 54(S2). https://doi.org/10.1111/eci.14344

Vancouver

Patarrão RS, Meneses MJ, Ghadieh HE, Herrera L, Duarte S, Ribeiro RT, et al. Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study. European Journal of Clinical Investigation. 2024;54(S2). doi:10.1111/eci.14344

BibTeX
@article{Patarro2024,
  author = {Patarrão, Rita S and Meneses, Maria João and Ghadieh, Hilda E and Herrera, Laura and Duarte, Sérgio and Ribeiro, Rogério T and Raposo, João F and Schmitt, Verena and Singer, Bernhard B and Gastaldelli, Amalia and Penha-Gonçalves, Carlos and Najjar, Sonia M and Macedo, M Paula},
  title = {Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  volume = {54},
  number = {S2},
  doi = {10.1111/eci.14344}
}
Kostenlos starten →